BRIEF-Supernus receives Nasdaq non-compliance notice

* Supernus Pharmaceuticals says currently anticipates

regaining compliance with filing requirement by filing its

quarterly report prior to January 13, 2017

Source text for Eikon:

Further company...

Read more